Product containing precisely tapentadol 150 milligram/1 each modified-release oral tablet 1 tablet tablet (clinical drug)
| Code | 18671911000001101 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
777675005Tapentadol
medicinal product
10363801000001108Virtual medicinal product
product
39585511000001109Ationdo SR 150mg tablets (Grunenthal Ltd)
real clinical drug
43000011000001105Lupaxis 150mg prolonged-release tablets (Dr Reddy's Laboratories (UK) Ltd)
real clinical drug
18664411000001101Palexia SR 150mg tablets (Grunenthal Ltd)
real clinical drug
42675111000001109Tadomon 150mg prolonged-release tablets (G.L. Pharma UK Ltd)
real clinical drug
42898911000001102Tapentadol 150mg modified-release tablets (A A H Pharmaceuticals Ltd)
real clinical drug
42618811000001103Tapentadol 150mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
real clinical drug
42997711000001108Tapentadol 150mg modified-release tablets (Aspire Pharma Ltd)
real clinical drug
42540911000001108Tapentadol 150mg modified-release tablets (Krka UK Ltd)
real clinical drug
43142611000001104Tapentadol 150mg modified-release tablets (Medical Valley Invest AB)
real clinical drug
43157711000001107Tapentadol 150mg modified-release tablets (Medihealth (Northern) Ltd)
real clinical drug
42770611000001102Tapentadol 150mg modified-release tablets (Viatris UK Healthcare Ltd)
real clinical drug
43215111000001106Vecicom 150mg prolonged-release tablets (Celix Pharma Ltd)
real clinical drug